SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL). [electronic resource]
Producer: 20101015Description: 633-6 p. digitalISSN:- 1365-2141
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.